Skip to main content

plain-language-summary

Rewrite dense or technical text into a clear plain-language summary with a fixed structure (TL;DR, why it matters, key points, caveats). Use when the user asks to summarize, simplify, explain, "put this in plain language", or make something readable for a general / non-expert audience.

Quellinformationen

Repository
K-Dense-AI/skill-101-webinar
Letzte Quellaktivität
7. Juli 2026 um 00:19
Erkannte Sprache von SKILL.md
Englisch
Sterne
8
Forks
5

Installationsoptionen

Standardmäßig ist der Prompt ausgewählt, der zuerst die Quelle prüft. Sie können zu einem direkten Befehl wechseln oder eine lokale Kopie herunterladen.

Quelldateien prüfen

Lesen Sie SKILL.md und alle von SkillsMP angezeigten Begleitdateien, bevor Sie sich für eine Installation entscheiden.

SKILL.md wird angezeigt

SKILL.md
Quellanweisungen · Schreibgeschützte Vorschau
name
plain-language-summary
description
Rewrite dense or technical text into a clear plain-language summary with a fixed structure (TL;DR, why it matters, key points, caveats). Use when the user asks to summarize, simplify, explain, "put this in plain language", or make something readable for a general / non-expert audience.
# Plain-Language Summary ## When to use Any time the user wants technical, jargon-heavy, or dense material made clear for a general reader — abstracts, documentation, reports, emails, papers. ## Output format (ALWAYS use exactly this) **TL;DR:** one plain sentence anyone could understand. **Why it matters:** 1–2 sentences on the real-world significance. **Key points:** - 3–5 bullets, each jargon-free and self-contained. **Caveats:** what's uncertain, assumed, or out of scope (1–2 bullets). ## Rules - No jargon without a 3-word plain explanation in parentheses. - Prefer everyday words; cut filler. - Keep the whole thing under ~200 words unless the user asks for more. - Never invent facts that aren't in the source text; if something is unclear, say so in Caveats. ## Example Input: "We employed a randomized double-blind placebo-controlled trial (n=240) to assess the efficacy of compound X on LDL-C reduction over 12 weeks." Output: **TL;DR:** A careful study tested whether drug X lowers "bad" cholesterol, and it did. **Why it matters:** Lower bad cholesterol usually means lower heart-disease risk. **Key points:** - 240 people took part over 12 weeks. - Neither patients nor doctors knew who got the real drug (double-blind), which reduces bias. - Some got a fake pill (placebo) for comparison. **Caveats:** - 12 weeks is short — long-term effects aren't shown here.
Auf GitHub ansehen